The estimated Net Worth of Stuart J Collinson is at least $25.3 Milion dollars as of 14 December 2006. Stuart Collinson owns over 50,019 units of Vertex Pharmaceuticals stock worth over $25,302,693 and over the last 21 years Stuart sold VRTX stock worth over $0.
Stuart has made over 7 trades of the Vertex Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Stuart exercised 50,019 units of VRTX stock worth $909,345 on 14 December 2006.
The largest trade Stuart's ever made was exercising 50,019 units of Vertex Pharmaceuticals stock on 14 December 2006 worth over $909,345. On average, Stuart trades about 8,847 units every 11 days since 2003. As of 14 December 2006 Stuart still owns at least 53,298 units of Vertex Pharmaceuticals stock.
You can see the complete history of Stuart Collinson stock trades at the bottom of the page.
Stuart's mailing address filed with the SEC is 203 REDWOOD SHORES PKWY, STE 500, , REDWOOD CITY, CA, 94065.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden oraz Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: